RENAISSANCE TECHNOLOGIES LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1037389
NEW YORK, NY
Position in AQST
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,731,591
-$945,433 QoQ
Shares Held
416,248
+0.4% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 185 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. AQST ranks #29 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in AQST
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,731,591 | 416,248 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $2,677,024 | 414,400 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $486,330 | 87,000 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $339,624 | 95,400 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $142,428 | 28,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,290,120 | 496,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,860,908 | 1,375,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,568,430 | 1,271,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,727,659 | 1,129,189 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,029,823 | 1,230,196 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $591,432 | 518,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $417,388 | 462,737 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,053,936 | 900,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $784,896 | 1,226,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $89,523 | 34,300 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $43,789 | 11,257 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $826,956 | 189,669 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $974,428 | 245,448 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $1,454,130 | 271,800 | Shares | Sole | 2021-02-10 | |
| 2020-03-31 | $643,971 | 294,051 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||